Evaluation of magnolia bark extract in chromosomal aberration assays

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 654, Issue 2, 2008, Pages 133-137

  Zhang, Baowei ^a   Maniatis, Theodore ^a   Song, Yan ^b   Zhang, Wenzhong ^b   Zhang, Xiaopeng ^b   Li, Ning ^b   Chen, Junshi ^b   Wong, Andrea W ^c   Roberts, Ashley ^c  

^a Nucro Technics   (Canada)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Cantox Health Sciences International   (Canada)

Author keywords

Chromosome aberration; Genotoxicity; Magnolia bark extract (MBE); Mutagenicity; Safety

Indexed keywords

CYCLOPHOSPHAMIDE; EUDESMOL; HONOKIOL; MAGNOLIA OFFICINALIS EXTRACT; MAGNOLOL; MITOMYCIN C;

ANIMAL CELL; ARTICLE; BARK; CELL STRAIN V 79; CHO CELL; CHROMOSOME ABERRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ISOLATION; DRUG SAFETY; GENOTOXICITY; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CHO CELLS; CHROMOSOME ABERRATIONS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; LUNG; MAGNOLIA; MUTAGENICITY TESTS; PLANT BARK; PLANT EXTRACTS;

CRICETULUS GRISEUS; MAGNOLIA;

EID: 47849124025     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2008.05.009     Document Type: Article

References (26)

1. Chang M.-H., and But P.P.-H. Houpo [Magnolia officinalis]. In: Chang M.-H., and But P.P.-H. (Eds). Pharmacology and Applications of Chinese Materia-Medica vol. 2 (1986), World Scientific, PA 878-880
2. Fujita M., Itokawa H., and Sashida Y. Honokiol, a new phenolic compounds isolated from the bark of magnolia obovata Thunb. Chem. Pharm. Bull. 20 (1972) 212-213
3. Zhao Z., Hu M., Sashida Y., and Tang X. Pharmacological studies on the magnolia bark. Determination of magnolol and honokiol in "hou po" (cortex magnoliae) prepared from the bark of different age. Shoyakugaku Zasshi 45 (1991) 45-147
4. Hsieh M.T., Chueh F.Y., and Lin M.T. Magnolol decreases body temperature by reducing 5-hydroxytryptamine release in the rat hypothalamus. Clin. Exp. Pharmacol. Physiol. 25 (1998) 813-817
5. Bang K.H., Kim Y.K., Min B.S., Na M.K., Rhee Y.H., and Lee J.P. Antifungal activity of magnolol and honokiol. Arch. Pharm. Res. 23 (2000) 46-49
6. Konoshima T., Kozuka M., Tokuda H., Nishino H., Iwashima A., Haruna M., Ito K., and Tanabe M. Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J. Nat. Prod. 54 (1991) 16-822
7. Nagase H., Ikeda K., and Sakai Y. Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro. Planta Med. 67 (2001) 705-708
8. Ikeda K., Sakai Y., and Nagase H. Inhibitory effect of magnolol on tumour metastasis in mice. Phytother. Res. 17 (2003) 933-937
9. Ikeda K., and Nagase H. Magnolol has the ability to induce apoptosis in tumor cells. Biol. Pharm. Bull. 25 (2002) 1546-1549
10. Fujita S., and Taira J. Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic. Biol. Med. 17 (1994) 273-277
11. Saito J., Sakai Y., and Nagase H. In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens. Mutat. Res. 609 (2006) 68-73
12. Yang H.-Y., and Chen C.-F. Subacute toxicity of 15 commonly used Chinese drugs (II). Yao Wu Shi Pin Fen Xi 5 (1997) 355-379
13. Yang H.-Y., and Chen C.-F. Pharmacology and toxicology of herbal medicine: subacute toxicity of commonly used Chinese drugs. J. Toxicol. Sci. Suppl. 23 (1998) 229-233
14. Liu Z., Zhang X., Cui W., Zhang X., Li N., Chen J., Wong A.W., and Roberts A. Evaluation of short-term and subchronic toxicity of magnolia bark extract in rats. Regul. Toxicol. Pharmacol. 49 (2007) 160-171
15. Hisinaga A., Itoh T., Hasegawa Y., Emore K., Kita T., Okabe A., and Kurachi M.A. A case of sleep choking syndrome improved by the Kampo extract of Hange-koboku-to. Psychiatry Clin. Neurosci. 56 (2002) 237-325
16. Iwasaki K., Cyong J.-C., Kitada S., Kitamura H., Ozeki J.-I., Satoh Y., Suzuki T., and Sasaki H. A traditional Chinese herbal medicine, banxia houpo tang, improves cough reflex of patients with aspiration pneumonia. J. Am. Geriatr. Soc. 50 (2002) 1751-1752
17. Mantani N., Hisanaga A., Kogure T., Kita T., Shimada Y., and Terasawa K. Four cases of panic disorder successfuly treated with Kampo (Japanese herbal) medicines: Kami-shoyo-san and Hange-koboku-to. Psychiatry Clin. Neurosci. 56 (2002) 617-620
18. Oikawa T., Ito G., Koyama H., and Hanawa T. Prokinetic effect of a Kampo medicien, Hange-koboku-to (Banxia-houpo-tang), on patients with functional dyspepsia. Phytomedicine 12 (2005) 730-734
19. Garrison R., and Chambliss W.G. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial. Altern. Ther. Health Med. 12 (2006) 50-54
20. Mucci M., Carraro C., Mancino P., Monti M., Papdia L.S., Volpinin G., and Benvenuti C. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva Ginecol. 58 (2006) 323-334
21. Li N., Song Y., Zhang W., Wang W., Chen J., Wong A.W., and Roberts A. Evaluation of the in vitro and in vivo genotoxicity of magnolia bark extract. Regul. Toxicol. Pharmacol. 49 (2007) 154-159
22. USP. Physical test <791> pH, in: United States Pharmacopeia. 29th ed. (2006), U.S. Pharmacopeia (USP) Convention Inc, Rockville, MD pp. 2730-2731
23. USP. Physical test <785> Osmolality and osmolarity. United States Pharmacopeia. 29th ed. (2006), U.S. Pharmacopeia (USP) Convention Inc, Rockville, MD pp. 2718-2719
24. Evans H.J. Cytological methods for detecting chemical mutagens. In: Hollaender A. (Ed). Chemical Mutagens, Principles and Methods for their Detection vol. 4 (1976), Plenum Press, New York, NY 1-29
25. Scott D., Dean B.J., Danford N.D., and Kirkland D.J. Metaphase chromosome aberration assays in vitro. In: Kirkland D.J., Gatehouse D.G., Scott D., Cole J., and Richold M. (Eds). Basic Mutagenicity Tests: UKEMS Recommended Procedures (1990), Cambridge University Press, Cambridge/New York 62-86
26. OECD In Vitro mammalian chromosome aberration test, in: OECD Guidelines for the Testing of Chemicals, Organization for Economic Co-operation and Development (OECD), Paris, France, OECD Guideline no. 473 (adopted July 21, 1997).